CUB NASDAQ Week ended 24 Jul 2026

Weekly Investor Report

Lionheart Holdings · Financial Services · Shell Companies

Open interactive chart View report data Download investor PDF
Latest close 10.80 USD
0.1% latest week
Weekly setup

Constructive, but selective

The weekly trend is active. Price is 0.3% above the Trend Line and sits at 45.2% of its 52-week range. The latest completed week returned 0.1%, after a 0.2% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive. The latest news-sentiment score is 51/100. Near-term considerations: earnings are due in 13d.

Setup score 63 out of 100
Latest Close 10.80 USD 24 Jul 2026
1W Return 0.1% latest completed week
4W Return 0.2% short-term follow-through
12W Return 0.0% quarterly tape
Trend Breadth 100.0% 52 of 52 weeks active
Volume Ratio 1.8x vs 13-week average
What is working
  • The trend backdrop is active with a 74-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Price is above Fair Value, showing premium demand versus the model.
  • Volume is elevated versus the 13-week average, confirming attention.
What could go wrong
  • Activity pressure is negative, which weakens the current setup.
What to watch next
  • Price is close to its 52-week high; watch for continuation or exhaustion.
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through 0.1% Latest completed week; four-week move 0.2%. Indicator stack 100/25 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. News sentiment 51/100 51 relevant articles in the latest sentiment read. Event risk 13d Next report is scheduled for 11 Aug 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is 0.3% above the Trend Line and sits at 45.2% of its 52-week range. The latest completed week returned 0.1%, after a 0.2% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 1.8x the 13-week average. Participation is unusually strong and confirms that the move is attracting attention.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
30 Jan 6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.7712-week average 0.93

12-week confirmation

Trend active12/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure9/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.77Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 0.2% over four weeks, 0.0% over 12 weeks, and 2.9% over one year. The current trend has remained active for 74 consecutive weeks.

Performance by holding period

1W0.1%
4W0.2%
12W0.0%
26W0.9%
52W2.9%
Active trend streak74 weeks
Active weeks in one year52
Trend breadth100.0%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure-0.72Latest activity-pressure read.
Pressure change-152.5%Four-week change in activity pressure.
Leadership-7.48Latest relative-leadership reading.
RS change37.3%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Dec 2025 Field coverage 67% Model confidence 64%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength54/100Blend of value, momentum, and quality. Underlying universe rank 47; rank 1 is best.
Value51/100Relative valuation strength. Underlying universe rank 50; rank 1 is best.
Quality49/100Profitability and accounting quality. Underlying universe rank 52; rank 1 is best.
Momentum51/100Medium-term price momentum. Underlying universe rank 50; rank 1 is best.
Growth51/100Revenue and earnings growth. Underlying universe rank 50; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
32.5x
Price divided by trailing earnings.
Price / sales
-
Market value relative to trailing revenue.
EV / EBITDA
-
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
-0.2%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
-
Gross profit retained from each unit of revenue.
Operating margin
-
Operating profit retained from revenue.
Free-cash-flow margin
-
Free cash flow generated from revenue.
Return on invested capital
-
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
-
Latest one-year revenue growth.
EPS growth
-5.9%
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-
Latest one-year free-cash-flow growth.
Piotroski F-score
2/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
-
Cash dividends relative to market value.
Buyback yield
0.0%
Net share repurchases relative to market value.
Shareholder yield
0.0%
Dividend yield plus net buyback yield.
Net debt / EBITDA
0.1x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity-

No recent insider transactions are stored for this company.

News sentiment51/100

Weighted news tone is neutral across 51 relevant articles.

5 positive · 44 neutral · 2 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings13dNext report is scheduled for 11 Aug 2026; event risk rises as the date approaches.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-3.8%Distance below the 52-week high.
13-week volatility0.3%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher15 of 268 weeks finished lower.
Best week+0.6%Week of 5 Jun.
Worst week-0.9%Week of 26 Jun.
Latest week+0.1%Week of 24 Jul.

Shape of recent returns

Strong gains0
Modest gains15
Flat weeks3
Modest losses8
Sharp losses0
Recent vol0.3%13-week weekly-return volatility.
Base vol0.3%52-week weekly-return volatility.
Up/down split27/13Count of positive and negative weeks in the 52-week window.
Average skew0.2% / -0.2%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape65/100

Trend, activity pressure, participation, and risk combine to a 65/100 tape read.

 Indicator analysis63/100

Latest 12-week confirmation: trend 12/12, activity pressure 9/12, relative leadership 0/12.

Activity pressure 0.77; No reversal markers Factors50/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 50; Small Cap Core rank 54 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Sentiment51/100

Weighted news tone is neutral across 51 relevant articles.

Lionheart Holdings (CUB) Earnings Forecast: Future EPS & Revenue Growth Estimates Insiders50/100

No recent insider transaction evidence is stored.

 Earnings13d

Next report is scheduled for 11 Aug 2026; event risk rises as the date approaches.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
24 Jul 202610.80 USD0.1%10.76 USD10.44 USD-0.72-7.483.3MOn
17 Jul 202610.79 USD-0.0%10.76 USD10.43 USD-0.70-9.3319.8KOn
10 Jul 202610.79 USD-0.1%10.75 USD10.43 USD-0.11-13.3875.2KOn
3 Jul 202610.81 USD0.3%10.75 USD10.43 USD0.58-12.09178.7KOn
26 Jun 202610.78 USD-0.9%10.74 USD10.42 USD1.37-11.944.1MOn
19 Jun 202610.88 USD0.0%10.73 USD10.42 USD1.82-15.502.1MOn
12 Jun 202610.88 USD-0.1%10.73 USD10.41 USD1.57-13.757.8MOn
5 Jun 202610.89 USD0.6%10.72 USD10.41 USD1.37-12.164.7MOn
29 May 202610.83 USD0.2%10.71 USD10.40 USD1.17-16.991.2MOn
22 May 202610.81 USD0.1%10.70 USD10.40 USD1.21-15.261.6KOn
15 May 202610.80 USD-0.1%10.69 USD10.39 USD1.62-14.81204.9KOn
8 May 202610.81 USD0.1%10.68 USD10.39 USD1.78-15.4462.3KOn
1 May 202610.80 USD-0.2%10.68 USD10.39 USD1.69-11.4591.2KOn
24 Apr 202610.82 USD0.2%10.67 USD10.38 USD1.83-10.4163.5KOn
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.